Miniatura

Fitxers

s41467-025-65806-9.pdf (1.98 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2025-11-17

Llicència de publicació

cc-by (c) Pera, Joan et al., 2025
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/224965

Human iPSCs-based modeling unveils SETBP1 as a driver of chromatin rewiring in GATA2 deficiency

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1038/s41467-025-65806-9

Resum

Patients with GATA2 deficiency are predisposed to developing myelodysplastic neoplasms (MDS), which can progress to acute myeloid leukemia. This progression is often associated with cytogenetic and somatic alterations. Mutations in SETBP1 and ASXL1 genes are recurrently observed in GATA2 patients, although their roles remain poorly understood. Here we develop a hiPSC-based system to investigate the impact of SETBP1 and ASXL1 mutations in GATA2 deficiency. Using precise genome editing, we recreate stepwise mutational trajectories observed in GATA2-related MDS. We demonstrate that GATA2 mutation has limited impact on hematopoietic progenitors, while the co-occurrence of SETBP1 or ASXL1 mutations impairs myeloid differentiation. The combination of all three mutations severely depletes myeloid progenitors, recapitulating GATA2-related MDS and highlighting their synergistic interplay. Notably, SETBP1 mutation plays a dominant role in establishing a stable chromatin accessibility landscape, even when co-occurring with ASXL1. Our study establishes an iPSC-based model of GATA2 deficiency, offering new insights into myeloid disease progression and a platform for testing future therapeutic strategies.

Matèries

Oncogens, Hematopoesi, Proteïnes supressores de tumors

Matèries (anglès)

Oncogenes, Hematopoiesis, Tumor suppressor protein

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Patologia i Terapèutica Experimental)

Citació

PERA, Joan, ROMERO MOYA, Damià, TORRALBA SALES, Eric, ANDERSSON, Rebecca, GARCÍA HERNÁNDEZ, Violeta, MAGALLON MOSELLA, Maria, DISTEFANO, Maximiliano, BERENGUER BALAGUER, Clara, CASTAÑO, Julio, DE GIORGIO, Francesca, QIU, Zhichao, IGLESIAS, Arnau, SPURK, Paulina, MONTSERRAT VAZQUEZ, Sara, PASQUALI, Lorenzo, LIANG, Zhuobin, CATALÀ, Albert, FLORIAN, Maria carolina, WLODARSKI, Marcin w., BIGAS, Anna, MARIN BEJAR, Oskar, GIORGETTI, Alessandra. Human iPSCs-based modeling unveils SETBP1 as a driver of chromatin rewiring in GATA2 deficiency. _Nature Communications_. 2025. Vol. 16, núm. 10035. [consulta: 30 de gener de 2026]. ISSN: 2041-1723. [Disponible a: https://hdl.handle.net/2445/224965]

Exportar metadades

JSON - METS

Compartir registre